B. Riley analyst Alex Rygiel initiated coverage of Centrus Energy with a Buy rating and $72 price target. Centrus has “an important lead” in High-Assay Low-Enriched Uranium, or HALEU, production, with the only NRC license and its meets national security mission requirements for domestic enrichment, the analyst tells investors. Centrus will be a beneficiary of federal funding, which could drive private investment, the analyst added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LEU: